Common sense or evidence: an optimal place for right and left ventricular leads? I. Eli Ovsyshcher EditorialNotes 16 April 2015 Pages: 1 - 3
Localization of pacing and defibrillator leads using standard x-ray views is frequently inaccurate and is not reproducible Larry R. Jackson IIJonathan P. Piccini Sr.Brett D. Atwater OriginalPaper 27 February 2015 Pages: 5 - 12
Comparison of pharmacological treatment alone versus treatment combined with cardiac resynchronization therapy in patients over 75 years Elena de la CruzMarcelino CortésJosé M. Rubio OriginalPaper 17 February 2015 Pages: 13 - 20
Ambulatory respiratory rate trends identify patients at higher risk of worsening heart failure in implantable cardioverter defibrillator and biventricular device recipients: a novel ambulatory parameter to optimize heart failure management Stephan GoetzeYi ZhangDries Kestens OriginalPaper Open access 12 April 2015 Pages: 21 - 29
Biomarkers in electrophysiology: role in arrhythmias and resynchronization therapy Abhishek BoseQuynh A. TruongJagmeet P. Singh REVIEWS 27 February 2015 Pages: 31 - 44
Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter-defibrillator implantation. The MODALITY study Maria Stella BaccillieriGianni GaspariniRoberto Verlato MULTIMEDIA REPORT 19 February 2015 Pages: 45 - 54
Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator Jordana KronWilliam SauerThomas Crawford OriginalPaper 13 February 2015 Pages: 55 - 64
A prospective study of anxiety in ICD patients with a pilot randomized controlled trial of cognitive behavioral therapy for patients with moderate to severe anxiety Mohammed QintarJason J. GeorgeMina K. Chung MULTIMEDIA REPORT 17 March 2015 Pages: 65 - 75
Subcutaneous implantable cardioverter defibrillator device malfunction: first report of a “high current” condition triggering device failure Kelvin C. LauMaully J. Shah CASE REPORTS 20 February 2015 Pages: 77 - 77
Left atrial appendage occlusion for prevention of stroke in nonvalvular atrial fibrillation: a meta-analysis Weeranun D. BodeNikhil PatelAnil K. Gehi MULTIMEDIA REPORT 25 February 2015 Pages: 79 - 89
The effect of C-reactive protein reduction with a highly specific antisense oligonucleotide on atrial fibrillation assessed using beat-to-beat pacemaker Holter follow-up Conn SugiharaNick FreemantleNeil Sulke OriginalPaper 25 February 2015 Pages: 91 - 98
Ischemic necrosis of the left atrial appendage at autopsy 4 weeks following epicardial suture ligation via a sub-xiphoid approach (LARIAT) Christopher R. EllisJanet M. ByrdSonia Lea Scalf CASE REPORTS 11 April 2015 Pages: 99 - 100
Erratum to: A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers Michael D. EzekowitzKenneth A. EllenbogenAndrew Koren Erratum 11 April 2015 Pages: 101 - 101